An associate in Covington’s Chambers top-ranked Food, Drug & Device Practice Group, Olivia Dworkin helps medical device, digital health, and technology companies bring innovative products to market while ensuring regulatory compliance. Her practice focuses on emerging technologies, including clinical decision support software, general wellness products, mobile medical applications, and AI-enabled tools. Olivia advises clients on the development, FDA regulatory classification, and commercialization of digital health tools across the product lifecycle, and regularly counsels on the implications of FDA guidance. She frequently contributes to Covington’s Digital Health blog and has published on digital health issues in leading legal journals and industry publications.